PSX
37
2
TMO
60
4
CAT
58
-8
ORCL
33
7
ADT
50
2
KMB
31
-11
PH
62
2
AES
47
-3
BIIB
50
4
ALL
56
2
NSC
48
-11
MU
75
4
APA
53
5
UNP
38
2
ADP
54
-4
MMM
56
2
CNX
49
3
LUV
68
2
NDAQ
74
4
MLM
67
4
PSX
37
2
TMO
60
4
CAT
58
-8
ORCL
33
7
ADT
50
2
KMB
31
-11
PH
62
2
AES
47
-3
BIIB
50
4
ALL
56
2
NSC
48
-11
MU
75
4
APA
53
5
UNP
38
2
ADP
54
-4
MMM
56
2
CNX
49
3
LUV
68
2
NDAQ
74
4
MLM
67
4
Financhill
Back

Sylvania Platinum Ltd. Vs. Nektar Therapeutics Industry Stock Comparison

Buy
59

SAPLF
Sylvania Platinum Ltd.

Last Price:
$1.33
Seasonality Move:
15.78%
Sell
46

NKTR
Nektar Therapeutics

Last Price:
$46.82
Seasonality Move:
6.44%
Buy
59
Sylvania Platinum Ltd. (SAPLF) is a Buy

Is Sylvania Platinum Ltd. a Buy, Sell or Hold?

  • The current Sylvania Platinum Ltd. [SAPLF] share price is $1.33. The Score for SAPLF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • SAPLF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SAPLF Stock Price Chart

What is Sylvania Platinum Ltd.'s stock price today?

  • The Sylvania Platinum Ltd. share price today is $1.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SAPLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $46.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SAPLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.25 Buy
Relative Strength Index (14 RSI): 62.01 Buy
Chaikin Money Flow: 1800 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.12 - 1.26) Buy
Bollinger Bands (100): (1.03 - 1.23) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 857593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.69 - 61.39) Sell
Bollinger Bands (100): (34.99 - 62.73) Sell

SAPLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.26 Buy
20-day SMA: 1.21 Buy
50-day SMA: 1.18 Buy
200-day SMA: 0.96 Buy
8-day EMA: 0.69 Buy
20-day EMA: 0.34 Buy
50-day EMA: 0.15 Buy
200-day EMA: 0.04 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.29 Sell
20-day SMA: 55.51 Sell
50-day SMA: 57.37 Sell
200-day SMA: 31.53 Buy
8-day EMA: 49.58 Sell
20-day EMA: 53.48 Sell
50-day EMA: 54.29 Sell
200-day EMA: 38.34 Buy

Sylvania Platinum Ltd. Earnings Growth & SAPLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

Sylvania Platinum Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):